Investing.com - USANA Health Sciences reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
USANA Health Sciences announced earnings per share of $0.78 on revenue of $233.00. Analysts polled by Investing.com EPS of $0.92 on revenue of $245.95M.
USANA Health Sciences 's are down 37% and is trading at $49.00 , still down 44.01% from its 52 week high of $103.95 set on Wednesday, November 17, 2021.
USANA Health Sciences shares lost 15.81% to trade at $49.00 in after-hours trade the report.
USANA Health Sciences follows other major Consumer Staples sector earnings this month
USANA Health Sciences's report follows an earnings beat by Procter&Gamble on Wednesday, October 19, 2022, who reported EPS of $1.57 on revenue of $20.6B, EPS of $1.56 on revenue of $20.37B.
Coca-Cola had beat expectations on Tuesday with third quarter EPS of $0.69 on revenue of $11.1B, for EPS of $0.64 on revenue of $10.53B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar